Sheba Mc

Ramat Gan 5265601

2 studies enrolling now · 10 studies all time

What they study most

Atypical Hemolytic Uremic Syndrome, Cardiac Disease, Episodic Migraine, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Hidradenitis Suppurativa, Hypercholesterolemia, Intestinal Malabsorption, Pancreatic Cancer, Premature Birth of Newborn, Primary Membranous Nephropathy, Systemic Sclerosis

Studies at this site

• A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis — Recruiting now
• A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) — Recruiting now
• A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS) — Running, not enrolling
• A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy — Running, not enrolling
• Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa — Completed
• Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants — Stopped early
• ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study — Completed
• Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients — Completed
• Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia — Completed
• Study for the Assessment of the Quality of Echocardiographic Clips. — Completed